Survival rates from small trial suggest that adding pazopanib to standard treatment for Ewing sarcoma in children may extend lives without adding severe toxicity.

Milton Yu, PhD, is the head of automation and analytics strategy at Benchling. Prior to Benchling, he was principal product manager at AWS and a director of GTM at Microsoft. Milton received his cell ...

The company's multi-year strategy involves the rollout of new products and upgrades to existing ones that further strengthen its position.

The Dog Aging Project analyzed blood samples from companion dogs to uncover ptmAAs as biological markers of aging.

Choosing the right materials and production methods can help make the single-use plastics used in drug making more sustainable.

Non-invasive device worn on the forehead uses laser technology and an array of detectors, and could form the basis of methods for monitoring brain blood flow.

Swiss researchers have devised an easy-to-implement method for calibrating Raman-based models for analyte prediction.

Optimizing icIEF identifies mAbs more accurately, while staying within European Pharmacopoeia and ICH guidelines.

St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.

This expansion is intended to eventually establish a novel research center named the Center for Mine Waste Biotechnology.

Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.

A pan-immunotherapy biomarker predicts and reactivates CD8⁺ T cell expansion, offering new insight into treatment response.